U.S. Pharmaceutical Sales - Q1 2013
The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q1 2013. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q1 2013 by sales
- Sales Statistics Q1 2013
- Units*
Rank |
Drug |
Sales ($000) |
|
|
1 |
Abilify Otsuka Pharmaceutical Co., Ltd |
1,526,228 |
3.24% |
Stats |
2 |
Nexium AstraZeneca |
1,458,964 |
1.21% |
Stats |
3 ( 1) |
Cymbalta
|
1,296,843 |
5.65% |
Stats |
4 ( 1) |
Crestor AstraZeneca |
1,295,760 |
1.59% |
Stats |
5 ( 1) |
Advair Diskus GlaxoSmithKline |
1,277,171 |
6.00% |
Stats |
6 ( 1) |
Humira AbbVie Inc. |
1,217,353 |
0.91% |
Stats |
7 |
Enbrel Amgen Inc. |
1,075,249 |
-1.22% |
Stats |
8 |
Remicade Janssen Pharmaceuticals, Inc. |
969,058 |
3.58% |
Stats |
9 |
Copaxone Teva Pharmaceuticals USA, Inc. |
926,021 |
1.98% |
Stats |
10 |
Neulasta Amgen Inc. |
859,062 |
6.94% |
Stats |
11 |
Rituxan Genentech, Inc. |
794,464 |
1.98% |
Stats |
12 |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
726,057 |
3.39% |
Stats |
13 |
Atripla Gilead Sciences, Inc. |
723,408 |
4.03% |
Stats |
14 ( 1) |
Januvia Merck |
701,126 |
6.40% |
Stats |
15 ( 1) |
OxyContin Purdue Pharma LP |
652,536 |
-2.38% |
Stats |
16 |
Avastin Genentech, Inc. |
640,823 |
1.04% |
Stats |
17 ( 1) |
Lantus Solostar Sanofi |
637,157 |
6.60% |
Stats |
18 ( 1) |
Lantus Sanofi |
592,333 |
-1.17% |
Stats |
19 ( 2) |
Lyrica
|
553,016 |
8.10% |
Stats |
20 ( 3) |
Diovan Novartis Pharmaceuticals Corporation |
538,141 |
13.39% |
Stats |
21 ( 2) |
Truvada Gilead Sciences, Inc. |
536,928 |
-5.11% |
Stats |
22 |
Celebrex
|
518,329 |
2.47% |
Stats |
23 ( 3) |
Epogen Amgen Inc. |
503,493 |
-2.08% |
Stats |
24 |
Herceptin Genentech, Inc. |
471,387 |
1.43% |
Stats |
25 |
Namenda Allergan plc |
448,659 |
-1.32% |
Stats |
26 |
Gleevec Novartis Pharmaceuticals Corporation |
438,105 |
0.41% |
Stats |
27 ( 1) |
Vyvanse Takeda Pharmaceutical Company Limited |
430,909 |
5.48% |
Stats |
28 ( 1) |
Suboxone
|
415,929 |
-0.32% |
Stats |
29 ( 1) |
Lucentis Genentech, Inc. |
415,406 |
4.92% |
Stats |
30 ( 16) |
Synagis MedImmune, Inc. |
412,703 |
46.47% |
Stats |
31 ( 1) |
Zetia Merck |
395,066 |
5.27% |
Stats |
32 ( 32) |
Tamiflu
|
392,115 |
65.38% |
Stats |
33 ( 4) |
methylphenidate Generic |
383,354 |
-4.09% |
Stats |
34 ( 3) |
Symbicort AstraZeneca |
376,822 |
10.70% |
Stats |
35 ( 1) |
OneTouch
|
368,604 |
5.36% |
Stats |
36 ( 5) |
enoxaparin Generic |
365,091 |
-7.37% |
Stats |
37 ( 1) |
AndroGel AbbVie Inc. |
348,205 |
0.49% |
Stats |
38 ( 3) |
Lidoderm Endo Pharmaceuticals Inc. |
345,620 |
-0.86% |
Stats |
39 ( 6) |
Avonex Biogen |
338,236 |
-9.05% |
Stats |
40 |
Levemir Novo Nordisk |
335,926 |
8.81% |
Stats |
41 ( 3) |
Rebif EMD Serono, Inc. |
332,452 |
6.61% |
Stats |
42 ( 3) |
Novolog Novo Nordisk |
322,779 |
3.74% |
Stats |
43 ( 1) |
NovoLog FlexPen Novo Nordisk |
316,981 |
7.97% |
Stats |
44 |
Seroquel XR AstraZeneca |
304,400 |
6.81% |
Stats |
45 ( 2) |
Viagra
|
288,880 |
-0.69% |
Stats |
46 ( 9) |
Nasonex Merck |
283,875 |
8.87% |
Stats |
47 ( 1) |
Niaspan AbbVie Inc. |
281,011 |
4.80% |
Stats |
48 ( 8) |
Humalog Eli Lilly and Company |
279,018 |
8.17% |
Stats |
49 ( 8) |
Alimta Eli Lilly and Company |
273,747 |
-8.17% |
Stats |
50 ( 2) |
budesonide Generic |
271,635 |
2.21% |
Stats |
51 ( 27) |
fenofibrate Generic |
268,473 |
29.97% |
Stats |
52 ( 1) |
Lovaza GlaxoSmithKline |
267,926 |
0.70% |
Stats |
53 ( 6) |
Flovent HFA GlaxoSmithKline |
266,820 |
-0.67% |
Stats |
54 ( 1) |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
266,777 |
0.65% |
Stats |
55 ( 6) |
amphetamine/dextroamphetamine Generic |
265,628 |
-0.69% |
Stats |
56 ( 11) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
262,338 |
-7.84% |
Stats |
57 ( 6) |
Cialis Eli Lilly and Company |
253,451 |
6.81% |
Stats |
58 ( 1) |
acetaminophen/hydrocodone Generic |
251,964 |
1.58% |
Stats |
59 ( 1) |
Isentress Merck |
243,636 |
2.00% |
Stats |
60 ( 8) |
Victoza Novo Nordisk |
242,143 |
6.43% |
Stats |
61 ( 3) |
Procrit Janssen Pharmaceuticals, Inc. |
241,175 |
-2.24% |
Stats |
62 ( 7) |
Janumet Merck |
240,005 |
7.64% |
Stats |
63 ( 4) |
Neupogen Amgen Inc. |
239,937 |
3.86% |
Stats |
64 ( 2) |
Reyataz Bristol-Myers Squibb Company |
238,094 |
0.18% |
Stats |
65 |
Restasis Allergan plc |
237,475 |
1.89% |
Stats |
66 ( 7) |
metoprolol Generic |
236,279 |
-1.41% |
Stats |
67 ( 1) |
Gilenya Novartis Pharmaceuticals Corporation |
235,496 |
1.18% |
Stats |
68 ( 18) |
Incivek Vertex Pharmaceuticals Incorporated |
234,084 |
-12.08% |
Stats |
69 ( 3) |
Prezista Janssen Pharmaceuticals, Inc. |
226,038 |
4.35% |
Stats |
70 ( 7) |
VESIcare Astellas Pharma US, Inc. |
220,271 |
5.33% |
Stats |
71 |
Vytorin Merck |
220,100 |
-0.81% |
Stats |
72 ( ) |
hydrochlorothiazide/valsartan Generic |
219,951 |
n/a |
Stats |
73 ( 19) |
modafinil Generic |
218,612 |
-17.44% |
Stats |
74 |
Orencia Bristol-Myers Squibb Company |
216,942 |
2.68% |
Stats |
75 ( 4) |
Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc. |
215,003 |
4.76% |
Stats |
76 ( 7) |
Renvela Sanofi |
210,975 |
4.77% |
Stats |
77 ( 2) |
Dexilant Takeda Pharmaceutical Company Limited |
210,005 |
-0.08% |
Stats |
78 ( 5) |
Aciphex Eisai Inc. |
209,443 |
-1.84% |
Stats |
79 ( 7) |
Benicar Daiichi Sankyo |
204,717 |
5.92% |
Stats |
80 ( 4) |
Aranesp Amgen Inc. |
203,664 |
-3.03% |
Stats |
81 ( 12) |
Stelara Janssen Pharmaceuticals, Inc. |
201,950 |
10.71% |
Stats |
82 ( ) |
Humalog KwikPen Eli Lilly and Company |
201,646 |
n/a |
Stats |
83 ( 5) |
Synthroid AbbVie Inc. |
200,695 |
5.21% |
Stats |
84 ( 5) |
Evista
|
197,559 |
4.03% |
Stats |
85 ( 5) |
Ventolin HFA GlaxoSmithKline |
197,453 |
6.00% |
Stats |
86 ( 5) |
Adderall XR Takeda Pharmaceutical Company Limited |
196,427 |
-3.21% |
Stats |
87 ( 5) |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
195,574 |
-3.20% |
Stats |
88 ( 4) |
atorvastatin Generic |
193,260 |
-1.47% |
Stats |
89 ( ) |
doxycycline Generic |
193,240 |
n/a |
Stats |
90 ( 3) |
Lunesta Sunovion Pharmaceuticals Inc. |
189,289 |
-1.43% |
Stats |
91 ( 6) |
fentanyl Generic |
189,255 |
-2.58% |
Stats |
92 ( 5) |
Zyvox Pfizer Inc. |
188,084 |
11.15% |
Stats |
93 ( 2) |
Xolair
|
182,221 |
-0.33% |
Stats |
94 ( 2) |
Xgeva Amgen Inc. |
182,194 |
4.84% |
Stats |
95 ( 15) |
Prevnar 13 Pfizer Inc. |
180,661 |
-11.69% |
Stats |
96 ( 4) |
Sensipar Amgen Inc. |
180,218 |
-1.31% |
Stats |
97 ( 2) |
Xeloda Genentech, Inc. |
174,526 |
-2.21% |
Stats |
98 ( ) |
omeprazole Generic |
172,664 |
n/a |
Stats |
99 ( 1) |
Focalin XR Novartis Pharmaceuticals Corporation |
171,147 |
1.74% |
Stats |
100 ( ) |
Benicar HCT Daiichi Sankyo |
170,433 |
n/a |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.